Director Catherine Owen resigns from OptiNose board to become CEO of Acadia Pharmaceuticals

OptiNose, Inc.

Catherine Owen resigned from the OptiNose board effective September 24, 2024.
Resignation was not due to any disagreement with the company on operations, policies, or practices.
Owen has been appointed Chief Executive Officer of Acadia Pharmaceuticals (NASDAQ: ACAD).
No successor was announced; board size is reduced accordingly.
OptiNose thanked Owen for her service and contributions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Catherine Owen

Director

OptiNose, Inc.

Effective: 2024-09-24
Filed: September 25, 2024, 7:59 PM ET

Ms. Catherine Owen resigned from the Board of Directors of OptiNose, Inc. (the "Company") on September 24, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Catherine Owen resigned as Director at OptiNose, Inc..

Action: resigned
Role: Director

Exact text from the filing

Ms. Catherine Owen resigned from the Board of Directors of OptiNose, Inc. (the "Company") on September 24, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001494650-24-000137

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.